Product NDC: | 62011-0161 |
Proprietary Name: | Senna-S |
Non Proprietary Name: | DOCUSATE SODIUM, SENNOSIDES |
Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; DOCUSATE SODIUM, SENNOSIDES |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62011-0161 |
Labeler Name: | McKesson |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20120518 |
Package NDC: | 62011-0161-1 |
Package Description: | 1 BOTTLE, PLASTIC in 1 BOX (62011-0161-1) > 60 TABLET, COATED in 1 BOTTLE, PLASTIC |
NDC Code | 62011-0161-1 |
Proprietary Name | Senna-S |
Package Description | 1 BOTTLE, PLASTIC in 1 BOX (62011-0161-1) > 60 TABLET, COATED in 1 BOTTLE, PLASTIC |
Product NDC | 62011-0161 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | DOCUSATE SODIUM, SENNOSIDES |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20120518 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | McKesson |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Strength Number | 50; 8.6 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |